Actavis to shed 310 jobs in shutdown of NC plant

When Actavis ($ACT) and Watson Pharmaceuticals merged last year, top managers warned that layoffs and shutdowns would follow. Now, Actavis says it's planning to close a plant in North Carolina--and cut 310 jobs in the process. Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.